<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35632526</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Persistent Enterovirus Infection: Little Deletions, Long Infections.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10050770</ELocationID><Abstract><AbstractText>Enteroviruses have now been shown to persist in cell cultures and in vivo by a novel mechanism involving the deletion of varying amounts of the 5' terminal genomic region termed domain I (also known as the cloverleaf). Molecular clones of coxsackievirus B3 (CVB3) genomes with 5' terminal deletions (TD) of varying length allow the study of these mutant populations, which are able to replicate in the complete absence of wildtype virus genomes. The study of TD enteroviruses has revealed numerous significant differences from canonical enteroviral biology. The deletions appear and become the dominant population when an enterovirus replicates in quiescent cell populations, but can also occur if one of the cis-acting replication elements of the genome (CRE-2C) is artificially mutated in the element's stem and loop structures. This review discusses how the TD genomes arise, how they interact with the host, and their effects on host biology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Nora M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0002-3119-8772</Identifier><AffiliationInfo><Affiliation>Department of Pathology &amp; Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cis-acting replication element</Keyword><Keyword MajorTopicYN="N">coxsackievirus B</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">negative-strand initiation</Keyword><Keyword MajorTopicYN="N">persistent infection</Keyword><Keyword MajorTopicYN="N">positive-strand initiation</Keyword><Keyword MajorTopicYN="N">terminal deletion</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632526</ArticleId><ArticleId IdType="pmc">PMC9143164</ArticleId><ArticleId IdType="doi">10.3390/vaccines10050770</ArticleId><ArticleId IdType="pii">vaccines10050770</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Racaniello V.R. Picornaviridae: The Viruses and their Replication. In: Knipe D.M., Howley P.M., Cohen J.I., Griffin D.E., Lamb R.A., Martin M.A., Racaniello V.R., Roizman B., editors. Fields Virology. 6th ed. Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2013. pp. 453–489.</Citation></Reference><Reference><Citation>Pallansch M.A., Oberste M.S., Whitton J.L. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In: Knipe D.M., Howley P.M., Cohen J.I., Griffin D.E., Lamb R.A., Martin M.A., Racaniello V.R., Roizman B., editors. Fields Virology. 6th ed. Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2001. pp. 490–530.</Citation></Reference><Reference><Citation>Kim K.-S., Chapman N., Tracy S. The group B coxsackieviruses and myocarditis. Rev. Med. Virol. 2001;11:355–368. doi: 10.1002/rmv.326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.326</ArticleId><ArticleId IdType="pubmed">11746998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd R.E., Tamhankar M., Lernmark A. Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors? Annu. Rev. Med. 2022;73:483–499. doi: 10.1146/annurev-med-042320-015952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042320-015952</ArticleId><ArticleId IdType="pmc">PMC9242008</ArticleId><ArticleId IdType="pubmed">34794324</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A., Canu A., Kirschner P., Simon T., Mall G., Hofschneider P.H., Kandolf R. Synergistic Interaction of Interferon- and Interferon- in Coxsackievirus B3-Infected Carrier Cultures of Human Myocardial Fibroblasts. J. Infect. Dis. 1992;166:958–965. doi: 10.1093/infdis/166.5.985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.5.985</ArticleId><ArticleId IdType="pubmed">1328409</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteucci D., Paglianti M., Giangregorio A.M., Capobianchi M.R., Dianzani F., Bendinelli M. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J. Virol. 1985;56:651–654. doi: 10.1128/jvi.56.2.651-654.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.56.2.651-654.1985</ArticleId><ArticleId IdType="pmc">PMC252628</ArticleId><ArticleId IdType="pubmed">2997486</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren L.C., Holland J.J. Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology. 1974;60:579–583. doi: 10.1016/0042-6822(74)90352-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(74)90352-3</ArticleId><ArticleId IdType="pubmed">4367496</ArticleId></ArticleIdList></Reference><Reference><Citation>Martín J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals. 2006;34:117–122. doi: 10.1016/j.biologicals.2006.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biologicals.2006.02.005</ArticleId><ArticleId IdType="pubmed">16650772</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J., Gear J., Prinsloo F.R., Kahn M., Kirsch Z.G. Myocarditis of the newborn; an outbreak in a maternity home in Southern Rhodesia associated with Coxsackie group-B virus infection. S. Afr. Med. J. 1955;29:608–612.</Citation><ArticleIdList><ArticleId IdType="pubmed">13246767</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff J.F. Viral myocarditis. A review. Am. J. Pathol. 1980;101:425–484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1903609</ArticleId><ArticleId IdType="pubmed">6254364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoni M., Ciardo L., Tamburini C., Boncompagni A., Rossi C., Guidotti I., Garetti E., Lugli L., Iughetti L., Berardi A. Enteroviral Infections in the First Three Months of Life. Pathogens. 2022;11:60. doi: 10.3390/pathogens11010060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11010060</ArticleId><ArticleId IdType="pmc">PMC8782040</ArticleId><ArticleId IdType="pubmed">35056008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A., Gretteau P.-A., Wehbe M., Renois F., N’Guyen Y., Lévêque N., Vu M.N., Tracy S., Chapman N.M., Bruneval P., et al. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5′ Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Circulation. 2019;139:2326–2338. doi: 10.1161/CIRCULATIONAHA.118.035966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung W.-C.G., Rawlinson W., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35. doi: 10.1136/bmj.d35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d35</ArticleId><ArticleId IdType="pmc">PMC3033438</ArticleId><ArticleId IdType="pubmed">21292721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles N.E., Rose M.L., Taylor P., Banner N.R., Morgan-Capner P., Cunningham L., Archard L.C., Yacoub M.H. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation. 1989;80:1128–1136. doi: 10.1161/01.CIR.80.5.1128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.80.5.1128</ArticleId><ArticleId IdType="pubmed">2553297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J. Mol. Cell. Cardiol. 1990;22:403–414. doi: 10.1016/0022-2828(90)91476-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2828(90)91476-N</ArticleId><ArticleId IdType="pubmed">2167382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegand V., Tracy S., Chapman N., Wucherpfennig C. Enteroviral infection in end stage dilated cardiomyopathy. Klin. Wochenschr. 1990;68:914–920. doi: 10.1007/BF01649038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01649038</ArticleId><ArticleId IdType="pubmed">2175375</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S.J., Willcox A., Bone A.J., Foulis A.K., Morgan N.G. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009;52:1143–1151. doi: 10.1007/s00125-009-1276-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1276-0</ArticleId><ArticleId IdType="pubmed">19266182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandolf R., Klingel K., Zell R., Selink H.-C., Raab U., Schneider-Brachert W., Bültmann B. Molecular Pathogenesis of Enterovirus-Induced Myocarditis: Virus Persistence and Chronic Inflammation. Intervirology. 1993;35:140–151. doi: 10.1159/000150305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150305</ArticleId><ArticleId IdType="pubmed">8407241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandolf R., Klingel K., Mertsching H., Canu A., Hohenadl C., Zell R., Reimann B.Y., Heim A., McManus B.M., Foulis A.K., et al. Molecular studies on enteroviral heart disease: Patterns of acute and persistent infections. Eur. Heart J. 1991;12:49–55. doi: 10.1093/eurheartj/12.suppl_D.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/12.suppl_D.49</ArticleId><ArticleId IdType="pubmed">1655451</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoletti L., Hober D., Decoene C., Copin M.-C., Lobert P.-E., Dewilde A., Stankowiac C., Wattre P. Detection of enteroviral RNA by polymerase chain reaction in endomyocardial tissue of patients with chronic cardiac diseases. J. Med. Virol. 1996;48:53–59. doi: 10.1002/(SICI)1096-9071(199601)48:1&lt;53::AID-JMV9&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199601)48:1&lt;53::AID-JMV9&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">8825711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., Schultheiss H.-P. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction. Circulation. 2005;112:1965–1970. doi: 10.1161/CIRCULATIONAHA.105.548156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548156</ArticleId><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N., Renois F., Talmud D., Nguyen Y., Lesaffre F., Boulagnon C., Bruneval P., Fornes P., Andréoletti L. Quantitative Genomic and Antigenomic Enterovirus RNA Detection in Explanted Heart Tissue Samples from Patients with End-Stage Idiopathic Dilated Cardiomyopathy. J. Clin. Microbiol. 2012;50:3378–3380. doi: 10.1128/JCM.01612-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01612-12</ArticleId><ArticleId IdType="pmc">PMC3457437</ArticleId><ArticleId IdType="pubmed">22837323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey L., Lambert V., Wattré P., Andréoletti L. Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay. J. Med. Virol. 2001;64:133–140. doi: 10.1002/jmv.1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1028</ArticleId><ArticleId IdType="pubmed">11360245</ArticleId></ArticleIdList></Reference><Reference><Citation>Reetoo K.N., Osman S.A., Illavia S.J., Cameron-Wilson C.L., Banatvala J.E., Muir P. Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: Biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J. Gen. Virol. 2000;81:2755–2762. doi: 10.1099/0022-1317-81-11-2755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-11-2755</ArticleId><ArticleId IdType="pubmed">11038389</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Stephan S., Sauter M., Zell R., McManus B.M., Bültmann B., Kandolf R. Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J. Virol. 1996;70:8888–8895. doi: 10.1128/jvi.70.12.8888-8895.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.12.8888-8895.1996</ArticleId><ArticleId IdType="pmc">PMC190986</ArticleId><ArticleId IdType="pubmed">8971018</ArticleId></ArticleIdList></Reference><Reference><Citation>Destombes J., Couderc T., Thiesson D., Girard S., Wilt S.G., Blondel B. Persistent poliovirus infection in mouse motoneurons. J. Virol. 1997;71:1621–1628. doi: 10.1128/jvi.71.2.1621-1628.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.2.1621-1628.1997</ArticleId><ArticleId IdType="pmc">PMC191220</ArticleId><ArticleId IdType="pubmed">8995689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyu B., Matsumori A., Sato Y., Okada I., Chapman N.M., Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation. 1992;86:522–530. doi: 10.1161/01.CIR.86.2.522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.86.2.522</ArticleId><ArticleId IdType="pubmed">1322254</ArticleId></ArticleIdList></Reference><Reference><Citation>See D.M., Tilles J.G. Pathogenesis of Virus-Induced Diabetes in Mice. J. Infect. Dis. 1995;171:1131–1138. doi: 10.1093/infdis/171.5.1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/171.5.1131</ArticleId><ArticleId IdType="pubmed">7751687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam P.E., Schmidt A.M., Ytterberg S.R., Messner R.P. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J. Lab. Clin. Med. 1994;123:346–356.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133145</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaïdane H., Gharbi J., Lobert P.-E., Lucas B., Hiar R., Ben M’Hadheb M., Brilot F., Geenen V., Aouni M., Hober D. Prolonged Viral RNA Detection in Blood and Lymphoid Tissues from Coxsackievirus B4 E2 Orally-Inoculated Swiss Mice. Microbiol. Immunol. 2006;50:971–974. doi: 10.1111/j.1348-0421.2006.tb03874.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2006.tb03874.x</ArticleId><ArticleId IdType="pubmed">17179665</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio A.L.P., Baboonian C., McKenna W.J. Postviral autoimmune heart disease--fact or fiction? Eur. Heart J. 1997;18:1051–1055. doi: 10.1093/oxfordjournals.eurheartj.a015397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.eurheartj.a015397</ArticleId><ArticleId IdType="pubmed">9243136</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: Evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 2004;15:17–27. doi: 10.1002/rmv.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.445</ArticleId><ArticleId IdType="pubmed">15386590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearden D., Collett M., Quan P.L., Costa-Carvalho B.T., Sullivan K.E. Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy. J. Allergy Clin. Immunol. Pract. 2016;4:1059–1065. doi: 10.1016/j.jaip.2015.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2015.12.015</ArticleId><ArticleId IdType="pubmed">26883540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lwoff A. LYSOGENY. Bacteriol. Rev. 1953;17:269–337. doi: 10.1128/br.17.4.269-337.1953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/br.17.4.269-337.1953</ArticleId><ArticleId IdType="pmc">PMC180777</ArticleId><ArticleId IdType="pubmed">13105613</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson S.D., Chapman N., Hafenstein S., Tracy S. Variations of Coxsackievirus B3 Capsid Primary Structure, Ligands, and Stability Are Selected for in a Coxsackievirus and Adenovirus Receptor-Limited Environment. J. Virol. 2011;85:3306–3314. doi: 10.1128/JVI.01827-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01827-10</ArticleId><ArticleId IdType="pmc">PMC3067837</ArticleId><ArticleId IdType="pubmed">21270163</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M., Bertin A., Sane F., Gimeno J.-P., Fournier I., Salzet M., Engelmann I., Alidjinou E., Hober D. Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation. Microorganisms. 2021;9:1125. doi: 10.3390/microorganisms9061125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061125</ArticleId><ArticleId IdType="pmc">PMC8224704</ArticleId><ArticleId IdType="pubmed">34067388</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S., Klingel K., Lindig V., Dörner A., Zeichhardt H., Spiller O.B., Fechner H. Virus-Host Coevolution in a Persistently Coxsackievirus B3-Infected Cardiomyocyte Cell Line. J. Virol. 2011;85:13409–13419. doi: 10.1128/JVI.00621-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00621-11</ArticleId><ArticleId IdType="pmc">PMC3233118</ArticleId><ArticleId IdType="pubmed">21976640</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Kandolf R. The role of enterovirus replication in the development of acute and chronic heart muscle disease indifferent immunocompetent mouse strains.Scand. J. Infect. Dis. Suppl. 1993;88:79–85.</Citation><ArticleIdList><ArticleId IdType="pubmed">8390720</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A.S., Baltimore D. Defective Viral Particles and Viral Disease Processes. Nature. 1970;226:325–327. doi: 10.1038/226325a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/226325a0</ArticleId><ArticleId IdType="pubmed">5439728</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux L., Simon A.E., Holland J.J. Effects of Defective Interfering Viruses on Virus Replication and Pathogenesis In Vitro and In Vivo. Adv. Virus Res. 1991;40:181–211. doi: 10.1016/s0065-3527(08)60279-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0065-3527(08)60279-1</ArticleId><ArticleId IdType="pmc">PMC7131706</ArticleId><ArticleId IdType="pubmed">1957718</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Lott W., Lowry K., Jones A., Thu H.M., Aaskov J. Defective Interfering Viral Particles in Acute Dengue Infections. PLoS ONE. 2011;6:e19447. doi: 10.1371/journal.pone.0019447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019447</ArticleId><ArticleId IdType="pmc">PMC3084866</ArticleId><ArticleId IdType="pubmed">21559384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui W.-Y., Yuen C.-K., Li C., Wong W.M., Lui P.-Y., Lin C.-H., Chan K.-H., Zhao H., Chen H., To K.K.W., et al. SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection. Emerg. Microbes Infect. 2019;8:662–674. doi: 10.1080/22221751.2019.1611346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1611346</ArticleId><ArticleId IdType="pmc">PMC6534226</ArticleId><ArticleId IdType="pubmed">31084471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesko K.N., Fitzpatrick K.A., Ryan E.M., Shi P.-Y., Zhang B., Lennon N.J., Newman R.M., Henn M.R., Ebel G.D. Internally deleted WNV genomes isolated from exotic birds in New Mexico: Function in cells, mosquitoes, and mice. Virology. 2012;427:10–17. doi: 10.1016/j.virol.2012.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.01.028</ArticleId><ArticleId IdType="pmc">PMC3312038</ArticleId><ArticleId IdType="pubmed">22365325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilijevic J., Zamarreño N., Oliveros J.C., Rodriguez-Frandsen A., Gómez G., Rodriguez G., Pérez-Ruiz M., Rey S., Barba I., Pozo F., et al. Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients. PLoS Pathog. 2017;13:e1006650. doi: 10.1371/journal.ppat.1006650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006650</ArticleId><ArticleId IdType="pmc">PMC5638565</ArticleId><ArticleId IdType="pubmed">29023600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole C.N., Smoler D., Wimmer E., Baltimore D. Defective Interfering Particles of Poliovirus I. Isolation and Physical Properties. J. Virol. 1971;7:478–485. doi: 10.1128/jvi.7.4.478-485.1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.7.4.478-485.1971</ArticleId><ArticleId IdType="pmc">PMC356147</ArticleId><ArticleId IdType="pubmed">4329564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundquist R.E., Sullivan M., Maizel J.V. Characterization of a new isolate of polioviru defective interfering particles. Cell. 1979;18:759–769. doi: 10.1016/0092-8674(79)90129-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(79)90129-6</ArticleId><ArticleId IdType="pubmed">229964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogram S., Flanegan J.B. Non-template functions of viral RNA in picornavirus replication. Curr. Opin. Virol. 2011;1:339–346. doi: 10.1016/j.coviro.2011.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2011.09.005</ArticleId><ArticleId IdType="pmc">PMC3227123</ArticleId><ArticleId IdType="pubmed">22140418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S.K., Kräusslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 1988;62:2636–2643. doi: 10.1128/jvi.62.8.2636-2643.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.62.8.2636-2643.1988</ArticleId><ArticleId IdType="pmc">PMC253694</ArticleId><ArticleId IdType="pubmed">2839690</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul A.V., Wimmer E. Initiation of protein-primed picornavirus RNA synthesis. Virus Res. 2015;206:12–26. doi: 10.1016/j.virusres.2014.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.12.028</ArticleId><ArticleId IdType="pmc">PMC4476921</ArticleId><ArticleId IdType="pubmed">25592245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S., Tracy S., Tapprich W., Bailey J., Lee C.-K., Barry W.H., Chapman N.M. 5′-Terminal Deletions Occur in Coxsackievirus B3 during Replication in Murine Hearts and Cardiac Myocyte Cultures and Correlate with Encapsidation of Negative-Strand Viral RNA. J. Virol. 2005;79:7024–7041. doi: 10.1128/JVI.79.11.7024-7041.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7024-7041.2005</ArticleId><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold J., Andino R. Poliovirus Requires a Precise 5′ End for Efficient Positive-Strand RNA Synthesis. J. Virol. 2000;74:6394–6400. doi: 10.1128/JVI.74.14.6394-6400.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.14.6394-6400.2000</ArticleId><ArticleId IdType="pmc">PMC112146</ArticleId><ArticleId IdType="pubmed">10864650</ArticleId></ArticleIdList></Reference><Reference><Citation>Frohman M.A., Dush M.K., Martin G.R. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA. 1988;85:8998–9002. doi: 10.1073/pnas.85.23.8998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.23.8998</ArticleId><ArticleId IdType="pmc">PMC282649</ArticleId><ArticleId IdType="pubmed">2461560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A., Nguyen Y., Wehbe M., Renois F., Fornes P., Bani-Sadr F., Metz D., Andreoletti L. Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues. Emerg. Infect. Dis. 2016;22:1488–1490. doi: 10.3201/eid2208.160186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2208.160186</ArticleId><ArticleId IdType="pmc">PMC4982168</ArticleId><ArticleId IdType="pubmed">27434549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N.M., Kim K.-S., Drescher K.M., Oka K., Tracy S. 5′ terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology. 2008;375:480–491. doi: 10.1016/j.virol.2008.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.02.030</ArticleId><ArticleId IdType="pmc">PMC2440640</ArticleId><ArticleId IdType="pubmed">18378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M., N’Guyen Y., Mirand A., Henquell C., Lebreil A.L., Berri F., Bani-Sadr F., Lina B., Schuffenecker I., Andreoletti L., et al. Major 5′terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes. Sci. Rep. 2020;10:11947. doi: 10.1038/s41598-020-67648-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67648-5</ArticleId><ArticleId IdType="pmc">PMC7371739</ArticleId><ArticleId IdType="pubmed">32686697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud B., Horn C., Tapprich W.E. Structure of the 5′ Untranslated Region of Enteroviral Genomic RNA. J. Virol. 2019;93:e01288-19. doi: 10.1128/JVI.01288-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01288-19</ArticleId><ArticleId IdType="pmc">PMC6854513</ArticleId><ArticleId IdType="pubmed">31534036</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Salas E., Francisco-Velilla R., Fernandez J., Lozano G., Diaz-Toledano R. Picornavirus IRES elements: RNA structure and host protein interactions. Virus Res. 2015;206:62–73. doi: 10.1016/j.virusres.2015.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.01.012</ArticleId><ArticleId IdType="pubmed">25617758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloc A., Rai D.K., Rieder E. The Roles of Picornavirus Untranslated Regions in Infection and Innate Immunity. Front. Microbiol. 2018;9:485. doi: 10.3389/fmicb.2018.00485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00485</ArticleId><ArticleId IdType="pmc">PMC5870040</ArticleId><ArticleId IdType="pubmed">29616004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunziker I.P., Cornell C.T., Whitton J.L. Deletions within the 5′UTR of coxsackievirus B3: Consequences for virus translation and replication. Virology. 2007;360:120–128. doi: 10.1016/j.virol.2006.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.09.041</ArticleId><ArticleId IdType="pmc">PMC2190293</ArticleId><ArticleId IdType="pubmed">17084431</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Carthy C.M., Cheung P., Bohunek L., Wilson J.E., McManus B.M., Yang D. Structural and Functional Analysis of the 5′ Untranslated Region of Coxsackievirus B3 RNA: In Vivo Translational and Infectivity Studies of Full-Length Mutants. Virology. 1999;265:206–217. doi: 10.1006/viro.1999.0048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.0048</ArticleId><ArticleId IdType="pubmed">10600593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S., Chapman N., Tracy S. Replication of Coxsackievirus B3 in Primary Cell Cultures Generates Novel Viral Genome Deletions. J. Virol. 2008;82:2033–2037. doi: 10.1128/JVI.01774-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01774-07</ArticleId><ArticleId IdType="pmc">PMC2258713</ArticleId><ArticleId IdType="pubmed">18057248</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G.E., Baltimore D. A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA. Cell. 1990;63:369–380. doi: 10.1016/0092-8674(90)90170-J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90170-J</ArticleId><ArticleId IdType="pubmed">2170027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S., Smithee S., Alhazmi A., Chapman N. Coxsackievirus can persist in murine pancreas by deletion of 5′ terminal genomic sequences. J. Med. Virol. 2015;87:240–247. doi: 10.1002/jmv.24039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24039</ArticleId><ArticleId IdType="pubmed">25111164</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G.E., Trono D., Baltimore D. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5′ noncoding region. J. Virol. 1990;64:607–612. doi: 10.1128/jvi.64.2.607-612.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.2.607-612.1990</ArticleId><ArticleId IdType="pmc">PMC249150</ArticleId><ArticleId IdType="pubmed">2153227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlenschläger O., Wöhnert J., Bucci E., Seitz S., Häfner S., Ramachandran R., Zell R., Görlach M. The Structure of the Stemloop D Subdomain of Coxsackievirus B3 Cloverleaf RNA and Its Interaction with the Proteinase 3C. Structure. 2004;12:237–248. doi: 10.1016/j.str.2004.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2004.01.014</ArticleId><ArticleId IdType="pubmed">14962384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Sidigi K., Bucci E., Stelzner A., Görlach M. Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C. RNA. 2002;8:188–201. doi: 10.1017/S1355838202012785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355838202012785</ArticleId><ArticleId IdType="pmc">PMC1370242</ArticleId><ArticleId IdType="pubmed">11911365</ArticleId></ArticleIdList></Reference><Reference><Citation>Klump W.M., Bergmann I., Müller B.C., Ameis D., Kandolf R. Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 1990;64:1573–1583. doi: 10.1128/jvi.64.4.1573-1583.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.4.1573-1583.1990</ArticleId><ArticleId IdType="pmc">PMC249292</ArticleId><ArticleId IdType="pubmed">2157045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt D.A., Andino R. An RNA Element at the 5′-End of the Poliovirus Genome Functions as a General Promoter for RNA Synthesis. PLoS Pathog. 2010;6:e1000936. doi: 10.1371/journal.ppat.1000936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000936</ArticleId><ArticleId IdType="pmc">PMC2880563</ArticleId><ArticleId IdType="pubmed">20532207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo L., Smithee S., Tracy S., Chapman N. Domain I of the 5′ non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication. Virology. 2016;496:127–130. doi: 10.1016/j.virol.2016.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.05.021</ArticleId><ArticleId IdType="pubmed">27289561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd R.E. Nuclear proteins hijacked by mammalian cytoplasmic plus strand RNA viruses. Virology. 2015;479–480:457–474. doi: 10.1016/j.virol.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.03.001</ArticleId><ArticleId IdType="pmc">PMC4426963</ArticleId><ArticleId IdType="pubmed">25818028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Ogram S.A., Morasco B.J., Spear A., Chapman N.M., Flanegan J.B. Functional role of the 5′ terminal cloverleaf in Coxsackievirus RNA replication. Virology. 2009;393:238–249. doi: 10.1016/j.virol.2009.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.07.039</ArticleId><ArticleId IdType="pubmed">19732932</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H., Franco D., Fujita K., Paul A.V., Wimmer E. Replication of Poliovirus Requires Binding of the Poly(rC) Binding Protein to the Cloverleaf as Well as to the Adjacent C-Rich Spacer Sequence between the Cloverleaf and the Internal Ribosomal Entry Site. J. Virol. 2007;81:10017–10028. doi: 10.1128/JVI.00516-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00516-07</ArticleId><ArticleId IdType="pmc">PMC2045387</ArticleId><ArticleId IdType="pubmed">17609276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Ihle Y., Seitz S., Gündel U., Wutzler P., Görlach M. Poly(rC)-binding protein 2 interacts with the oligo(rC) tract of coxsackievirus B3. Biochem. Biophys. Res. Commun. 2008;366:917–921. doi: 10.1016/j.bbrc.2007.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.12.038</ArticleId><ArticleId IdType="pubmed">18086560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N., Garcia M., Bouin A., Nguyen J.H.C., Tran G.P., Andreoletti L., Semler B.L. Functional Consequences of RNA 5′-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation. J. Virol. 2017;91:e00423-17. doi: 10.1128/JVI.00423-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00423-17</ArticleId><ArticleId IdType="pmc">PMC5533909</ArticleId><ArticleId IdType="pubmed">28539455</ArticleId></ArticleIdList></Reference><Reference><Citation>Spear A., Ogram S.A., Morasco B.J., Smerage L.E., Flanegan J.B. Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex. Virology. 2015;485:492–501. doi: 10.1016/j.virol.2015.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.07.018</ArticleId><ArticleId IdType="pmc">PMC4780368</ArticleId><ArticleId IdType="pubmed">26303005</ArticleId></ArticleIdList></Reference><Reference><Citation>Smithee S., Tracy S., Chapman N.M. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5′-Terminal Genomic Deletions. J. Virol. 2015;89:11761–11772. doi: 10.1128/JVI.01308-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01308-15</ArticleId><ArticleId IdType="pmc">PMC4645312</ArticleId><ArticleId IdType="pubmed">26355088</ArticleId></ArticleIdList></Reference><Reference><Citation>Smithee S., Tracy S., Chapman N.M. Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C) Virus Res. 2016;220:136–149. doi: 10.1016/j.virusres.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.04.016</ArticleId><ArticleId IdType="pubmed">27130630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent C.I., Johnson K.L., Sarnow P., Kirkegaard K. Functional Coupling between Replication and Packaging of Poliovirus Replicon RNA. J. Virol. 1999;73:427–435. doi: 10.1128/JVI.73.1.427-435.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.1.427-435.1999</ArticleId><ArticleId IdType="pmc">PMC103849</ArticleId><ArticleId IdType="pubmed">9847348</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak J.E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 1991;65:3384–3387. doi: 10.1128/jvi.65.6.3384-3387.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.6.3384-3387.1991</ArticleId><ArticleId IdType="pmc">PMC241002</ArticleId><ArticleId IdType="pubmed">1851886</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte M.B., Andino R. Single-Cell Analysis Uncovers Extensive Biological Noise in Poliovirus Replication. J. Virol. 2014;88:6205–6212. doi: 10.1128/JVI.03539-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03539-13</ArticleId><ArticleId IdType="pmc">PMC4093869</ArticleId><ArticleId IdType="pubmed">24648454</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA. 1992;89:314–318. doi: 10.1073/pnas.89.1.314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.1.314</ArticleId><ArticleId IdType="pmc">PMC48227</ArticleId><ArticleId IdType="pubmed">1309611</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam P.E., Messner R.P. Molecular Mechanisms of Coxsackievirus Persistence in Chronic Inflammatory Myopathy: Viral RNA Persists through Formation of a Double-Stranded Complex without Associated Genomic Mutations or Evolution. J. Virol. 1999;73:10113–10121. doi: 10.1128/JVI.73.12.10113-10121.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.10113-10121.1999</ArticleId><ArticleId IdType="pmc">PMC113063</ArticleId><ArticleId IdType="pubmed">10559326</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Ruller C.M., An N., Tabor-Godwin J.M., Rhoades R.E., Maciejewski S., Pagarigan R.R., Cornell C.T., Crocker S.J., Kiosses W.B., et al. Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period. J. Virol. 2009;83:9356–9369. doi: 10.1128/JVI.02382-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02382-07</ArticleId><ArticleId IdType="pmc">PMC2738251</ArticleId><ArticleId IdType="pubmed">19570873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop J.M., Koch G. Purification and Characterization of Poliovirus-induced Infectious Double-stranded Ribonucleic Acid. J. Biol. Chem. 1967;242:1736–1743. doi: 10.1016/S0021-9258(18)96062-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)96062-X</ArticleId><ArticleId IdType="pubmed">4290440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse I., Peyret H., Saxena P., Lomonossoff G.P. Encapsidation of Viral RNA in Picornavirales: Studies on Cowpea Mosaic Virus Demonstrate Dependence on Viral Replication. J. Virol. 2019;93:e01520-18. doi: 10.1128/JVI.01520-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01520-18</ArticleId><ArticleId IdType="pmc">PMC6321914</ArticleId><ArticleId IdType="pubmed">30355698</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P., Liu Y., Ma H.-C., Paul A.V., Wimmer E. Picornavirus Morphogenesis. Microbiol. Mol. Biol. Rev. 2014;78:418–437. doi: 10.1128/MMBR.00012-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler-Bostock R., Mata C.P., Bingham R.J., Dykeman E.C., Meng B., Tuthill T.J., Rowlands D.J., Ranson N.A., Twarock R., Stockley P.G. Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts. PLoS Pathog. 2020;16:e1009146. doi: 10.1371/journal.ppat.1009146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009146</ArticleId><ArticleId IdType="pmc">PMC7793301</ArticleId><ArticleId IdType="pubmed">33370422</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M., Heng L., Callon D., Lebreil A.-L., Gretteau P.-A., Nguyen Y., Berri F., Andreoletti L. Structures and Functions of Viral 5′ Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections. Viruses. 2020;12:919. doi: 10.3390/v12090919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090919</ArticleId><ArticleId IdType="pmc">PMC7552046</ArticleId><ArticleId IdType="pubmed">32839386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak H.B., Arnold J.J., Wiegand P.N., Hargittai M.R.S., Cameron C.E. Picornavirus Genome Replication. J. Biol. Chem. 2007;282:16202–16213. doi: 10.1074/jbc.M610608200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M610608200</ArticleId><ArticleId IdType="pmc">PMC2116992</ArticleId><ArticleId IdType="pubmed">17392285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann O., Zdunek S., Felker A., Salehpour M., Alkass K., Bernard S., Sjostrom S.L., Szewczykowska M., Jackowska T., Dos Remedios C., et al. Dynamics of Cell Generation and Turnover in the Human Heart. Cell. 2015;161:1566–1575. doi: 10.1016/j.cell.2015.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.026</ArticleId><ArticleId IdType="pubmed">26073943</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcox A., Richardson S.J., Bone A.J., Foulis A.K., Morgan N.G. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia. 2011;54:2417–2420. doi: 10.1007/s00125-011-2192-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-011-2192-7</ArticleId><ArticleId IdType="pubmed">21597997</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Mena I., Pagarigan R., Slifka M.K., Whitton J.L. Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro. J. Virol. 2002;76:4430–4440. doi: 10.1128/JVI.76.9.4430-4440.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.9.4430-4440.2002</ArticleId><ArticleId IdType="pmc">PMC155066</ArticleId><ArticleId IdType="pubmed">11932410</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G.A., Lidsky P.V., Mikitas O.V., Egger D., Lukyanov K.A., Bienz K., Agol V.I. Bidirectional Increase in Permeability of Nuclear Envelope upon Poliovirus Infection and Accompanying Alterations of Nuclear Pores. J. Virol. 2004;78:10166–10177. doi: 10.1128/JVI.78.18.10166-10177.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.18.10166-10177.2004</ArticleId><ArticleId IdType="pmc">PMC514989</ArticleId><ArticleId IdType="pubmed">15331749</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner J.E., Ertel K.J., Rozovics J.M., Semler B.L. Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins. Virology. 2010;400:240–247. doi: 10.1016/j.virol.2010.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.01.031</ArticleId><ArticleId IdType="pmc">PMC2844484</ArticleId><ArticleId IdType="pubmed">20189623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.D., Chase A.J., Cathcart A.L., Tran G.P., Semler B.L. Viral Proteinase Requirements for the Nucleocytoplasmic Relocalization of Cellular Splicing Factor SRp20 during Picornavirus Infections. J. Virol. 2013;87:2390–2400. doi: 10.1128/JVI.02396-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02396-12</ArticleId><ArticleId IdType="pmc">PMC3571363</ArticleId><ArticleId IdType="pubmed">23255796</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoch K.-P., Nath-Sain S., Petzold A., Schneider H., Beck M., Wegbrod C., Sönmez A., Münster C., Friedrich A., Roivainen M., et al. PTBP1 is required for glucose-stimulated cap-independent translation of insulin granule proteins and Coxsackieviruses in beta cells. Mol. Metab. 2014;3:518–530. doi: 10.1016/j.molmet.2014.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2014.05.002</ArticleId><ArticleId IdType="pmc">PMC4099505</ArticleId><ArticleId IdType="pubmed">25061557</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.-Y., Shih S.-R., Pan M., Li C., Lue C.-F., Stollar V., Li M.-L. hnRNP A1 Interacts with the 5′ Untranslated Regions of Enterovirus 71 and Sindbis Virus RNA and Is Required for Viral Replication. J. Virol. 2009;83:6106–6114. doi: 10.1128/JVI.02476-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02476-08</ArticleId><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizcano-Perret B., Michiels T. Nucleocytoplasmic Trafficking Perturbation Induced by Picornaviruses. Viruses. 2021;13:1210. doi: 10.3390/v13071210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071210</ArticleId><ArticleId IdType="pmc">PMC8310216</ArticleId><ArticleId IdType="pubmed">34201715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullmer W., Semler B.L. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells. mBio. 2018;9:e01669-18. doi: 10.1128/mBio.01669-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01669-18</ArticleId><ArticleId IdType="pmc">PMC6123441</ArticleId><ArticleId IdType="pubmed">30181254</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A.C., Semler B.L. Picornaviruses and RNA Metabolism: Local and Global Effects of Infection. J. Virol. 2019;93:e02088-17. doi: 10.1128/JVI.02088-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02088-17</ArticleId><ArticleId IdType="pmc">PMC6803262</ArticleId><ArticleId IdType="pubmed">31413128</ArticleId></ArticleIdList></Reference><Reference><Citation>Schepens B., Tinton S.A., Bruynooghe Y., Parthoens E., Haegman M., Beyaert R., Cornelis S. A role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosis. EMBO J. 2006;26:158–169. doi: 10.1038/sj.emboj.7601468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601468</ArticleId><ArticleId IdType="pmc">PMC1782369</ArticleId><ArticleId IdType="pubmed">17159903</ArticleId></ArticleIdList></Reference><Reference><Citation>Piñol-Roma S., Dreyfuss G. Cell cycle-regulated phosphorylation of the pre-mRNA-binding (heterogeneous nuclear ribonucleoprotein) C proteins. Mol. Cell. Biol. 1993;13:5762–5770. doi: 10.1128/mcb.13.9.5762-5770.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.13.9.5762-5770.1993</ArticleId><ArticleId IdType="pmc">PMC360316</ArticleId><ArticleId IdType="pubmed">8395012</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakielny S., Dreyfuss G. The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals. J. Cell Biol. 1996;134:1365–1373. doi: 10.1083/jcb.134.6.1365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.6.1365</ArticleId><ArticleId IdType="pmc">PMC2121000</ArticleId><ArticleId IdType="pubmed">8830767</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.D., Grabowski P.J., Sharp P.A., Dreyfuss G. Heterogeneous Nuclear Ribonucleoproteins: Role in RNA Splicing. Science. 1986;231:1534–1539. doi: 10.1126/science.3952495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3952495</ArticleId><ArticleId IdType="pubmed">3952495</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviner R., Hofmann S., Elman T., Shenoy A., Geiger T., Elkon R., Ehrlich M., Elroy-Stein O. Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis. Nucleic Acids Res. 2017;45:5945–5957. doi: 10.1093/nar/gkx326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx326</ArticleId><ArticleId IdType="pmc">PMC5449605</ArticleId><ArticleId IdType="pubmed">28460002</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehl H.H., Parsley T.B., Ho T.V., Semler B.L. Processing of a cellular polypeptide by 3CD proteinase is required for poliovirus ribonucleoprotein complex formation. J. Virol. 1997;71:578–585. doi: 10.1128/jvi.71.1.578-585.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.1.578-585.1997</ArticleId><ArticleId IdType="pmc">PMC191087</ArticleId><ArticleId IdType="pubmed">8985386</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner J.E., Nguyen J.H.C., Roehl H.H., Ho T.V., Swiderek K.M., Semler B.L. Functional Interaction of Heterogeneous Nuclear Ribonucleoprotein C with Poliovirus RNA Synthesis Initiation Complexes. J. Virol. 2005;79:3254–3266. doi: 10.1128/JVI.79.6.3254-3266.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.6.3254-3266.2005</ArticleId><ArticleId IdType="pmc">PMC1075716</ArticleId><ArticleId IdType="pubmed">15731220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertel K.J., Brunner J.E., Semler B.L. Mechanistic Consequences of hnRNP C Binding to Both RNA Termini of Poliovirus Negative-Strand RNA Intermediates. J. Virol. 2010;84:4229–4242. doi: 10.1128/JVI.02198-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02198-09</ArticleId><ArticleId IdType="pmc">PMC2863767</ArticleId><ArticleId IdType="pubmed">20164237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L., Kim J.-K., Pollard V.W., Dreyfuss G. Mutational Definition of RNA-binding and Protein-Protein Interaction Domains of Heterogeneous Nuclear RNP C1. J. Biol. Chem. 2001;276:7681–7688. doi: 10.1074/jbc.M010207200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010207200</ArticleId><ArticleId IdType="pubmed">11113151</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave P., George B., Balakrishnan S., Sharma D.K., Raheja H., Dixit N.M., Das S. Strand-specific affinity of host factor hnRNP C1/C2 guides positive to negative-strand ratio in Coxsackievirus B3 infection. RNA Biol. 2019;16:1286–1299. doi: 10.1080/15476286.2019.1629208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2019.1629208</ArticleId><ArticleId IdType="pmc">PMC6693535</ArticleId><ArticleId IdType="pubmed">31234696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim B.-S., Wu W., Kyriakis C.S., Bakre A., Jorquera P.A., Perwitasari O., Tripp R.A. MicroRNA-555 has potent antiviral properties against poliovirus. J. Gen. Virol. 2016;97:659–668. doi: 10.1099/jgv.0.000372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000372</ArticleId><ArticleId IdType="pubmed">26683768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogram S.A., Boone C.D., McKenna R., Flanegan J.B. Amiloride inhibits the initiation of Coxsackievirus and poliovirus RNA replication by inhibiting VPg uridylylation. Virology. 2014;464–465:87–97. doi: 10.1016/j.virol.2014.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.06.025</ArticleId><ArticleId IdType="pmc">PMC4542153</ArticleId><ArticleId IdType="pubmed">25058507</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ooij M.J.M., Vogt D.A., Paul A., Castro C., Kuijpers J., Van Kuppeveld F.J.M., Cameron C.E., Wimmer E., Andino R., Melchers W.J.G. Structural and functional characterization of the coxsackievirus B3 CRE(2C): Role of CRE(2C) in negative- and positive-strand RNA synthesis. J. Gen. Virol. 2006;87:103–113. doi: 10.1099/vir.0.81297-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81297-0</ArticleId><ArticleId IdType="pubmed">16361422</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow I., Polacek C., Andino R., Evans D.J. The poliovirus 2C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. J. Gen. Virol. 2003;84:2359–2363. doi: 10.1099/vir.0.19132-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19132-0</ArticleId><ArticleId IdType="pubmed">12917456</ArticleId></ArticleIdList></Reference><Reference><Citation>Morasco B.J., Sharma N., Parilla J., Flanegan J.B. Poliovirus cre (2C)-Dependent Synthesis of VPgpUpU Is Required for Positive- but Not Negative-Strand RNA Synthesis. J. Virol. 2003;77:5136–5144. doi: 10.1128/JVI.77.9.5136-5144.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.9.5136-5144.2003</ArticleId><ArticleId IdType="pmc">PMC153981</ArticleId><ArticleId IdType="pubmed">12692216</ArticleId></ArticleIdList></Reference><Reference><Citation>Eruera A.-R., McSweeney A., McKenzie-Goldsmith G., Ward V. Protein Nucleotidylylation in +ssRNA Viruses. Viruses. 2021;13:1549. doi: 10.3390/v13081549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081549</ArticleId><ArticleId IdType="pmc">PMC8402628</ArticleId><ArticleId IdType="pubmed">34452414</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow I., Chaudhry Y., Richardson A., Meredith J., Almond J.W., Barclay W., Evans D.J. Identification of a cis -Acting Replication Element within the Poliovirus Coding Region. J. Virol. 2000;74:4590–4600. doi: 10.1128/JVI.74.10.4590-4600.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.10.4590-4600.2000</ArticleId><ArticleId IdType="pmc">PMC111979</ArticleId><ArticleId IdType="pubmed">10775595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder E., Paul A.V., Kim D.W., van Boom J.H., Wimmer E. Genetic and Biochemical Studies of Poliovirus cis -Acting Replication Element cre in Relation to VPg Uridylylation. J. Virol. 2000;74:10371–10380. doi: 10.1128/JVI.74.22.10371-10380.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.22.10371-10380.2000</ArticleId><ArticleId IdType="pmc">PMC110911</ArticleId><ArticleId IdType="pubmed">11044081</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowder S., Kirkegaard K. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 2005;37:701–709. doi: 10.1038/ng1583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1583</ArticleId><ArticleId IdType="pubmed">15965477</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul A.V., Van Boom J.H., Filippov D.V., Wimmer E. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature. 1998;393:280–284. doi: 10.1038/30529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/30529</ArticleId><ArticleId IdType="pubmed">9607767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry K., Woodman A., Cook J., Evans D.J. Recombination in Enteroviruses Is a Biphasic Replicative Process Involving the Generation of Greater-than Genome Length ‘Imprecise’ Intermediates. PLoS Pathog. 2014;10:e1004191. doi: 10.1371/journal.ppat.1004191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004191</ArticleId><ArticleId IdType="pmc">PMC4055744</ArticleId><ArticleId IdType="pubmed">24945141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Z., Chapman N.M., Hufnagel G., Tracy S., Romero J.R., Barry W.H., Zhao L., Currey K., Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol. 1995;69:4607–4618. doi: 10.1128/jvi.69.8.4607-4618.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.8.4607-4618.1995</ArticleId><ArticleId IdType="pmc">PMC189260</ArticleId><ArticleId IdType="pubmed">7609025</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoyer E., López C.B. The Impact of Defective Viruses on Infection and Immunity. Annu. Rev. Virol. 2019;6:547–566. doi: 10.1146/annurev-virology-092818-015652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092818-015652</ArticleId><ArticleId IdType="pubmed">31082310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely R., Klingel K., Santana L., Dalton N., Hongo M., Lederer W.J., Kandolf R., Knowlton K.U. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Investig. 1998;102:1444–1453. doi: 10.1172/JCI1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI1972</ArticleId><ArticleId IdType="pmc">PMC508992</ArticleId><ArticleId IdType="pubmed">9769337</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong D., Yajima T., Lim B.-K., Stenbit A., Dublin A., Dalton N.D., Summers-Torres D., Molkentin J., Duplain H., Wessely R., et al. Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy. Circulation. 2007;115:94–102. doi: 10.1161/CIRCULATIONAHA.106.631093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.631093</ArticleId><ArticleId IdType="pubmed">17190866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A., Semler B.L. Picornavirus Cellular Remodeling: Doubling Down in Response to Viral-Induced Inflammation. Curr. Clin. Microbiol. Rep. 2020;7:31–37. doi: 10.1007/s40588-020-00138-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-020-00138-4</ArticleId><ArticleId IdType="pmc">PMC7377643</ArticleId><ArticleId IdType="pubmed">32704466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird S.W., Maynard N.D., Covert M.W., Kirkegaard K. Nonlytic viral spread enhanced by autophagy components. Proc. Natl. Acad. Sci. USA. 2014;111:13081–13086. doi: 10.1073/pnas.1401437111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401437111</ArticleId><ArticleId IdType="pmc">PMC4246951</ArticleId><ArticleId IdType="pubmed">25157142</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-H., Du W., Hagemeijer M.C., Takvorian P.M., Pau C., Cali A., Brantner C.A., Stempinski E.S., Connelly P.S., Ma H.-C., et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160:619–630. doi: 10.1016/j.cell.2015.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.M., Tsueng G., Sin J., Mangale V., Rahawi S., McIntyre L.L., Williams W., Kha N., Cruz C., Hancock B.M., et al. Coxsackievirus B Exits the Host Cell in Shed Microvesicles Displaying Autophagosomal Markers. PLoS Pathog. 2014;10:e1004045. doi: 10.1371/journal.ppat.1004045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutsafi Y., Altan-Bonnet N. Enterovirus Transmission by Secretory Autophagy. Viruses. 2018;10:139. doi: 10.3390/v10030139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10030139</ArticleId><ArticleId IdType="pmc">PMC5869532</ArticleId><ArticleId IdType="pubmed">29558400</ArticleId></ArticleIdList></Reference><Reference><Citation>Altan-Bonnet N., Perales C., Domingo E. Extracellular vesicles: Vehicles of en bloc viral transmission. Virus Res. 2019;265:143–149. doi: 10.1016/j.virusres.2019.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2019.03.023</ArticleId><ArticleId IdType="pubmed">30928427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou J.-V., Geller R., Sanjuán R. Membrane-Associated Enteroviruses Undergo Intercellular Transmission as Pools of Sibling Viral Genomes. Cell Rep. 2019;29:714–723.e4. doi: 10.1016/j.celrep.2019.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.014</ArticleId><ArticleId IdType="pmc">PMC6899498</ArticleId><ArticleId IdType="pubmed">31618638</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma S., Rabouw H.H., Bruurs L.J., Pavlovič T., van Vliet A.L., Beumer J., Clevers H., van Kuppeveld F.J., Tanenbaum M.E. Translation and Replication Dynamics of Single RNA Viruses. Cell. 2020;183:1930–1945.e23. doi: 10.1016/j.cell.2020.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.019</ArticleId><ArticleId IdType="pmc">PMC7664544</ArticleId><ArticleId IdType="pubmed">33188777</ArticleId></ArticleIdList></Reference><Reference><Citation>McCune B.T., Lanahan M.R., Tenoever B.R., Pfeiffer J.K. Rapid Dissemination and Monopolization of Viral Populations in Mice Revealed Using a Panel of Barcoded Viruses. J. Virol. 2020;94:e01590-19. doi: 10.1128/JVI.01590-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01590-19</ArticleId><ArticleId IdType="pmc">PMC6955244</ArticleId><ArticleId IdType="pubmed">31666382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur S. Double-Stranded RNA Sensors and Modulators in Innate Immunity. Annu. Rev. Immunol. 2019;37:349–375. doi: 10.1146/annurev-immunol-042718-041356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041356</ArticleId><ArticleId IdType="pmc">PMC7136661</ArticleId><ArticleId IdType="pubmed">30673536</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.J., Langereis M.A., Rabouw H.H., Wahedi M., Muntjewerff E.M., de Groot R.J., van Kuppeveld F.J.M. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon. J. Virol. 2019;93:e00222-19. doi: 10.1128/JVI.00222-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells A.I., Coyne C.B. Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion. Viruses. 2019;11:460. doi: 10.3390/v11050460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050460</ArticleId><ArticleId IdType="pmc">PMC6563291</ArticleId><ArticleId IdType="pubmed">31117206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Paget M., Wang C., Zhu Z., Zheng H. Innate immune evasion by picornaviruses. Eur. J. Immunol. 2020;50:1268–1282. doi: 10.1002/eji.202048785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048785</ArticleId><ArticleId IdType="pubmed">32767562</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P., Nicholson F., Illavia S.J., McNeil T.S., Ajetunmobi J.F., Dunn H., Starkey W.G., Reetoo K.N., Cary N.R., Parameshwar J., et al. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart. 1996;76:243–249. doi: 10.1136/hrt.76.3.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.76.3.243</ArticleId><ArticleId IdType="pmc">PMC484515</ArticleId><ArticleId IdType="pubmed">8868984</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne J.L., Richardson S.J., Atkinson M.A., Craig M.E., Dahl-Jørgensen K., Flodström-Tullberg M., Hyöty H., Insel R.A., Lernmark Å., Lloyd R.E., et al. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia. 2019;62:744–753. doi: 10.1007/s00125-019-4811-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId><ArticleId IdType="pmc">PMC6450860</ArticleId><ArticleId IdType="pubmed">30675626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-H., Wang K., Zhao K., Hua S.-C., Du J. The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C. Front. Microbiol. 2020;11:615965. doi: 10.3389/fmicb.2020.615965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.615965</ArticleId><ArticleId IdType="pmc">PMC7767853</ArticleId><ArticleId IdType="pubmed">33381104</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Linden L., Wolthers K.C., Van Kuppeveld F.J.M. Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses. 2015;7:4529–4562. doi: 10.3390/v7082832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova A., Ekins S., Schmidtke M., Makarov V. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses. Eur. J. Med. Chem. 2019;178:606–622. doi: 10.1016/j.ejmech.2019.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.06.008</ArticleId><ArticleId IdType="pmc">PMC8194503</ArticleId><ArticleId IdType="pubmed">31226653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., Poller W., Schultheiss H.-P. Interferon-β Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients with Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction. Circulation. 2003;107:2793–2798. doi: 10.1161/01.CIR.0000072766.67150.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072766.67150.51</ArticleId><ArticleId IdType="pubmed">12771005</ArticleId></ArticleIdList></Reference><Reference><Citation>Meshram R.J., Kathwate G.H., Gacche R.N. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Arch. Virol. 2022;167:717–736. doi: 10.1007/s00705-022-05375-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-022-05375-0</ArticleId><ArticleId IdType="pmc">PMC8795940</ArticleId><ArticleId IdType="pubmed">35089390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>